You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dostarlimab

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

Not yet recruiting
  • Adenocarcinoma - GEJ
  • Gastric Adenocarcinoma
  • Dostarlimab
  • (no location specified)
Sep 26, 2023

Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)

Not yet recruiting
  • Recurrent Cancer
  • +2 more
  • Dostarlimab
  • Lyon, France
    Centre Léon Bérard
May 12, 2023

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

Not yet recruiting
  • Colonic Neoplasms
  • Dostarlimab
  • +2 more
  • (no location specified)
May 3, 2023

DOstarlimab in Recurrent or dMMR/MSI-H Endometrial Cancer

Not yet recruiting
  • Endometrial Cancer
  • Dostarlimab
  • (no location specified)
Feb 14, 2023

Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)

Not yet recruiting
  • Refractory HIV Associated Kaposi Sarcoma
  • Dostarlimab in Combination Antiretroviral Therapy
  • (no location specified)
Dec 2, 2022

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • Dostarlimab
  • +4 more
  • (no location specified)
Sep 3, 2023

Gestational Trophoblastic Neoplasia Trial in Miami (Dostarlimab)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Dostarlimab
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Nov 4, 2022

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Active, not recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jan 31, 2023

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023

Brain Metastases Trial in Houston (Niraparib, Dostarlimab)

Not yet recruiting
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)

Not yet recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2023

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

HRD, Cholangiocarcinoma, Metastatic Cancer Trial (Niraparib, Dostarlimab)

Withdrawn
  • HRD
  • +2 more
  • (no location specified)
Jun 23, 2022

Head and Neck Squamous Cell Carcinoma Trial in Spain (Dostarlimab, Niraparib, cisplatin plus radiotherapy)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Dostarlimab
  • +2 more
  • Badalona, Cataluña, Spain
  • +4 more
Mar 13, 2023

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 26, 2022

Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)

Recruiting
  • Rectal Neoplasms
  • Rectal Neoplasm Malignant
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Dostarlimab (TSR-042) (singly)
  • Dostarlimab (TSR-042) and TSR-022 (combination)
  • Washington, District of Columbia
  • +2 more
Feb 22, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Colon Cancer, DMMR Colorectal Cancer Trial (Dostarlimab)

Not yet recruiting
  • Colon Cancer
  • DMMR Colorectal Cancer
  • Dostarlimab
  • (no location specified)
Feb 4, 2022

Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

Recruiting
  • Neoplasms
  • Brno, Czechia
  • +20 more
Nov 21, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Oct 18, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +2 more
Apr 13, 2022

Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)

Recruiting
  • Endometrial Cancer
  • Intensity modulated radiation therapy (IMRT)
  • Dostarlimab
  • Basking Ridge, New Jersey
  • +6 more
Jul 5, 2022